Gamida Cell Ltd. Soared

Mon, Dec 07, 2020 at 05:30 PM

Gamida Cell Ltd. (GMDA:NASDAQ) rocketted at $10.89, a gain of 56.2%. The stock got featured on our News Catalysts scanner on Mon 07 Dec 20 at 05:25 PM in the 'BIOTECH' category. From Fri 20 Nov 20, the stock recorded 33.33% Up Days and 40.00% Green Days

The share price of the company has been moving sideways in recent weeks.

About Gamida Cell Ltd. (GMDA:NASDAQ)

Gamida Cell Ltd is engaged in the development of cellular and immune therapeutics for cancer and rare genetic diseases. The company's lead product candidate is NiCord, a nicotinamide (NAM)-expanded cord blood cell therapy for use as a curative stem cell graft for patients in hematopoietic stem cell transplant. It is also developing NAM-NK, an innate immunotherapy of expanded natural killer cells, for the treatment of refractory non-Hodgkin lymphoma and multiple myeloma.

Top 10 Gainers:

Obalon Therapeutics, Inc. (OBLN:NASDAQ), 114.95%
Eastman Kodak Company (KODK:NYSE), 59.89%
Gamida Cell Ltd. (GMDA:NASDAQ), 56.24%
Oncternal Therapeutics, Inc. (ONCT:NASDAQ), 49.62%
Greenland Technologies Holding Corporation (GTEC:NASDAQ), 49.37%
KBNT (KBNT:NASDAQ), 43.62%
HPK (HPK:NASDAQ), 39.6%
Fate Therapeutics, Inc. (FATE:NASDAQ), 37.8%
Hennessy Capital Acquisition Corp. IV (HCAC:NASDAQ), 35.32%
EHang Holdings Limited (EH:NASDAQ), 34.87%